Literature DB >> 19721090

Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.

Michele M Fluck1, Brian S Schaffhausen.   

Abstract

The small DNA tumor viruses have provided a very long-lived source of insights into many aspects of the life cycle of eukaryotic cells. In recent years, the emphasis has been on cancer-related signaling. Here we review murine polyomavirus middle T antigen, its mechanisms, and its downstream pathways of transformation. We concentrate on the MMTV-PyMT transgenic mouse, one of the most studied models of breast cancer, which permits the examination of in situ tumor progression from hyperplasia to metastasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19721090      PMCID: PMC2738132          DOI: 10.1128/MMBR.00009-09

Source DB:  PubMed          Journal:  Microbiol Mol Biol Rev        ISSN: 1092-2172            Impact factor:   11.056


  345 in total

Review 1.  Mechanisms of cell transformation by papillomavirus E5 proteins.

Authors:  D DiMaio; D Mattoon
Journal:  Oncogene       Date:  2001-11-26       Impact factor: 9.867

2.  The epidemiology of mouse polyoma virus infection.

Authors:  W P ROWE
Journal:  Bacteriol Rev       Date:  1961-03

3.  Association of protein phosphatase 2A with polyoma virus medium tumor antigen.

Authors:  G Walter; R Ruediger; C Slaughter; M Mumby
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

4.  Medium tumor antigen of polyomavirus transformation-defective mutant NG59 is associated with 73-kilodalton heat shock protein.

Authors:  G Walter; A Carbone; W J Welch
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

5.  Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice.

Authors:  Ioanna G Maroulakou; William Oemler; Stephen P Naber; Philip N Tsichlis
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

6.  Carboxy terminus of polyoma middle-sized tumor antigen is required for attachment to membranes, associated protein kinase activities, and cell transformation.

Authors:  G G Carmichael; B S Schaffhausen; D I Dorsky; D B Oliver; T L Benjamin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

7.  Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation.

Authors:  T E Kmiecik; D Shalloway
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

8.  Induction of tumor formation and cell transformation by polyoma middle T antigen in the absence of Src.

Authors:  J E Thomas; A Aguzzi; P Soriano; E F Wagner; J S Brugge
Journal:  Oncogene       Date:  1993-09       Impact factor: 9.867

9.  Enhancement of cellular src gene product associated tyrosyl kinase activity following polyoma virus infection and transformation.

Authors:  J B Bolen; C J Thiele; M A Israel; W Yonemoto; L A Lipsich; J S Brugge
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

10.  Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression.

Authors:  T Lifsted; T Le Voyer; M Williams; W Muller; A Klein-Szanto; K H Buetow; K W Hunter
Journal:  Int J Cancer       Date:  1998-08-12       Impact factor: 7.396

View more
  88 in total

1.  The polyomavirus middle T-antigen oncogene activates the Hippo pathway tumor suppressor Lats in a Src-dependent manner.

Authors:  M Shanzer; I Ricardo-Lax; R Keshet; N Reuven; Y Shaul
Journal:  Oncogene       Date:  2014-11-03       Impact factor: 9.867

Review 2.  Nuclear receptor coregulators: modulators of pathology and therapeutic targets.

Authors:  David M Lonard; Bert W O'Malley
Journal:  Nat Rev Endocrinol       Date:  2012-06-26       Impact factor: 43.330

3.  Unimpeded skin carcinogenesis in K14-HPV16 transgenic mice deficient for plasminogen activator inhibitor.

Authors:  Anne Masset; Catherine Maillard; Nor Eddine Sounni; Nathalie Jacobs; Françoise Bruyére; Philippe Delvenne; Marlene Tacke; Thomas Reinheckel; Jean-Michel Foidart; Lisa M Coussens; Agnès Noël
Journal:  Int J Cancer       Date:  2010-03-15       Impact factor: 7.396

Review 4.  Expression of novel proteins by polyomaviruses and recent advances in the structural and functional features of agnoprotein of JC virus, BK virus, and simian virus 40.

Authors:  A Sami Saribas; Pascale Coric; Serge Bouaziz; Mahmut Safak
Journal:  J Cell Physiol       Date:  2018-11-02       Impact factor: 6.384

Review 5.  How to Choose a Mouse Model of Breast Cancer, a Genomic Perspective.

Authors:  Matthew R Swiatnicki; Eran R Andrechek
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-06-21       Impact factor: 2.673

6.  Nondestructive Detection of Targeted Microbubbles Using Dual-Mode Data and Deep Learning for Real-Time Ultrasound Molecular Imaging.

Authors:  Dongwoon Hyun; Lotfi Abou-Elkacem; Rakesh Bam; Leandra L Brickson; Carl D Herickhoff; Jeremy J Dahl
Journal:  IEEE Trans Med Imaging       Date:  2020-04-09       Impact factor: 10.048

7.  Oncoprotein GT198 vaccination delays tumor growth in MMTV-PyMT mice.

Authors:  Bhagelu R Achyut; Hao Zhang; Kartik Angara; Nahid F Mivechi; Ali S Arbab; Lan Ko
Journal:  Cancer Lett       Date:  2020-02-12       Impact factor: 8.679

8.  Activation of DNA damage repair pathways by murine polyomavirus.

Authors:  Katie Heiser; Catherine Nicholas; Robert L Garcea
Journal:  Virology       Date:  2016-08-16       Impact factor: 3.616

9.  The E2F transcription factors regulate tumor development and metastasis in a mouse model of metastatic breast cancer.

Authors:  Daniel P Hollern; Jordan Honeysett; Robert D Cardiff; Eran R Andrechek
Journal:  Mol Cell Biol       Date:  2014-06-16       Impact factor: 4.272

10.  Transformation by Polyomavirus Middle T Antigen Involves a Unique Bimodal Interaction with the Hippo Effector YAP.

Authors:  Cecile Rouleau; Arun T Pores Fernando; Justin H Hwang; Nathalie Faure; Tao Jiang; Elizabeth A White; Thomas M Roberts; Brian S Schaffhausen
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.